Company or institution

Rigel Pharmaceuticals, Inc.

Save Like

278 applicationsfiled 2006 to 2025

Allowance rate

75%

level with the USPTO range 69% to 80%

Rejections before allowance

1.4

−0.2 vs the USPTO

Months to first action

10.8 mo

−7.8 vs the USPTO

Needed an RCE

−18 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07D Heterocyclic compounds144 apps

A61K Medical preparations90 apps

A61P Therapeutic activity of compounds18 apps

G01N Investigating or analysing materials9 apps

C07K Peptides6 apps

C07F 4 apps

Art units

1624107 apps

162633 apps

162517 apps

162117 apps

162214 apps

162914 apps

Examiners met

The examiners seen most, and how it went with each

Deepak R Rao31 apps

87%

Kahsay Habte18 apps

67%

Brenda Libby Coleman13 apps

92%

Ebenezer O Sackey12 apps

100%

Docket Central10 apps

n/a

Kamal A Saeed8 apps

100%

Bruck Kifle8 apps

71%

Golam M Shameem7 apps

100%

Bars show the share of decided applications that were allowed.

Unlock the examiners this company meetsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents on their applications

Rigel Pharmaceuticals, Inc.151 apps

91%

Jones Day36 apps

58%

Klarquist Sparkman, LLP (Rigel)28 apps

36%

ELI LILLY & COMPANY26 apps

76%

McDonnell Boehnen Hulbert & Berghoff LLP16 apps

38%

Seed IP Law Group LLP/Rigel Pharmaceuticals, Inc.13 apps

77%

BOZICEVIC, FIELD & FRANCIS LLP2 apps

GOODWIN PROCTER LLP2 apps

50%

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19499807	TREATMENT OF ACUTE MYELOID LEUKEMIA WITH OLUTASIDENIB, VENETOCLAX AND A HYPOMETHYLA…	2026-01-06	Pending	0	0	n/a
19410904	PHARMACEUTICAL COMPOSITIONS	2025-12-05	Pending	0	0	n/a
19411088	SOLID FORMS OF 1-(4-(4-((3-(3,6-DIFLUOROPYRIDIN-2-YL)-1-((1R,4R)-4-ETHOXYCYCLOHEXYL…	2025-12-05	Pending	0	0	n/a
15214204	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15967097	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15253474	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15149079	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15947065	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15420727	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15513035	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock all 278 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in